AKEBIA THERAPEUTICS

akebia-therapeutics-logo

Akebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme. Akebia Therapeutics, Inc. was founded in 2007 and is based in Cincinnati, Ohio.

#SimilarOrganizations #People #Financial #Website #More

AKEBIA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2007-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.akebia.com

Total Employee:
11+

Status:
Active

Contact:
(617) 871-2098

Email Addresses:
[email protected]

Total Funding:
340.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

adagio-medical-logo

Adagio Medical

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

adial-pharmaceuticals-logo

Adial Pharmaceuticals

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

akarna-therapeutics-logo

Akarna Therapeutics

At Akarna, our mission is to develop best-ยญin-ยญclass treatments for NASH and other chronic liver diseases

allinaire-therapeutics-logo

Allinaire Therapeutics

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

anavex-logo

Anavex

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.

arsenal-medical-logo

Arsenal Medical

Arsenal Medical develops novel products that improve local therapy for injuries and diseases.

atara-biotherapeutics-logo

Atara Biotherapeutics

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

biomx-logo

BIOMx

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

cerulean-pharma-logo

Cerulean Pharma

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

feldan-therapeutics-logo

Feldan Therapeutics

Feldan Therapeutics has developed a patented peptide-based technology platform.

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

galera-therapeutics-logo

Galera Therapeutics

Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.

neuropore-therapies-logo

Neuropore Therapies

San Diego-based Neuropore, a biopharmaceuticals firm developing treatments for Parkinson's disease.

novadigm-therapeutics-logo

NovaDigm Therapeutics

NovaDigm Therapeutics develops vaccines that protect patients from contracting fungal and bacterial infections.


Current Advisors List

muneer-a-satter_image

Muneer A. Satter Chairman @ Akebia Therapeutics
Board_member

ronald-renaud_image

Ronald Renaud Member of the Board of Directors @ Akebia Therapeutics
Board_member

jack-nielsen_image

Jack Nielsen Chairman of the Board of Directors @ Akebia Therapeutics
Board_member

leanne-zumwalt_image

LeAnne Zumwalt Board Member @ Akebia Therapeutics
Board_member
2021-02-01

anupam-dalal_image

Anupam Dalal Board of Directors @ Akebia Therapeutics
Board_member

paul-weiss_image

Paul Weiss Member of the Board of Directors @ Akebia Therapeutics
Board_member

cynthia-smith_image

Cynthia Smith Member Board Of Directors @ Akebia Therapeutics
Board_member
2018-01-01

joseph-gardner_image

Joseph Gardner Board Member @ Akebia Therapeutics
Board_member

Current Employees Featured

john-butler_image

John Butler
John Butler President & CEO @ Akebia Therapeutics
President & CEO
2013-09-01

not_available_image

Steven Burke
Steven Burke Chief Medical Officer @ Akebia Therapeutics
Chief Medical Officer
2019-08-01

peter-manni_image

Peter Manni
Peter Manni Director Strategic Sourcing @ Akebia Therapeutics
Director Strategic Sourcing
2019-12-01

Founder


joseph-gardner_image

Joseph Gardner

robert-shalwitz_image

Robert Shalwitz

Stock Details


Company's stock symbol is NASDAQ:AKBA

Acquisitions List

Date Company Article Price
2018-06-28 Keryx Biopharmaceuticals Keryx Biopharmaceuticals acquired by Akebia Therapeutics N/A

Investors List

pharmakon-advisors_image

Pharmakon Advisors

Pharmakon Advisors investment in Post-IPO Debt - Akebia Therapeutics

sigvion-capital_image

Orchard Venture Partners

Orchard Venture Partners investment in Series C - Akebia Therapeutics

kearny-venture-partners_image

Kearny Venture Partners

Kearny Venture Partners investment in Series C - Akebia Therapeutics

athenian-venture-partners_image

Athenian Venture Partners

Athenian Venture Partners investment in Series C - Akebia Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series C - Akebia Therapeutics

satter-investment-management_image

Satter Investment Management

Satter Investment Management investment in Series C - Akebia Therapeutics

triathlon-medical-venture-partners_image

Triathlon Medical Venture Partners

Triathlon Medical Venture Partners investment in Series C - Akebia Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Akebia Therapeutics

agechem-venture-fund_image

AgeChem Venture Fund

AgeChem Venture Fund investment in Series C - Akebia Therapeutics

venture-investors_image

Venture Investors

Venture Investors investment in Series C - Akebia Therapeutics

Official Site Inspections

http://www.akebia.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.89 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Akebia Therapeutics" on Search Engine